Kessler Topaz Meltzer & Check, LLP Reminds Investors of BioXcel Therapeutics, Inc. of Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa., Aug. 8, 2023 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Connecticut against BioXcel Therapeutics, Inc. (“BioXcel”) (NASDAQ: BTAI). The action charges BioXcel with violations of the federal securities … Read more